State University of New York at Buffalo
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, State University of New York at Buffalo sits in the top decile of US sponsors by registered trial count (#135 of 15,742 sponsors by registered trial count).
State University of New York at Buffalo: 243 sponsored US clinical trials, 52 recruiting.
State University of New York at Buffalo sponsors 243 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 156 completed. 19 of these trials are in Phase 3-4 (later-stage) and 26 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 4 trials.
Top-decile sponsor footprint
State University of New York at Buffalo ranks in the top decile of sponsors by registered trial count (#135 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 172 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
243 total, page 4 of 5
Weight Loss for Prediabetes Using Episodic Future Thinking
NCT03670602
Enhancing IEPs of Children With ADHD Using Daily Report Cards
NCT03747887
Music Intervention for Agitation Reduction in the Pediatric Intensive Care Unit
NCT03453814
Impact of Meditation on Bothersome Tinnitus
NCT03711630
Low Carb vs Normal Carb in Pregnancy
NCT03749889
Double Blinded Randomized Control Trial of Types of IVF in Children With DKA
NCT03066440
Comparison of Ophthalmoscopy Findings Using PanOptic vs PanOptic + iExaminer
NCT03860727
Postpartum Smoking Relapse Prevention by Breastfeeding Promotion
NCT04670822
Smartphone and 3D Printing Based Home Rehabilitation System for Chronic Stroke
NCT04363944
Glottic View in Infants With a Shoulder Roll
NCT03424070
Atrial Fibrillation Screening in Nursing Homes
NCT03860246
Pinhole Surgical Technique Compared to Connective Tissue Graft in Treatment of Gingival Recession
NCT04356391
Support for Caregivers of Older Adults With Cognitive Decline
NCT04787068
Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure
NCT04564378
Treating Violence-related PTSD and Substance Risk in Low-income, Urban Adolescents
NCT03737383
Primary Care Pediatrics Learning Activity and Nutrition With Families
NCT02873715
Technology Delivered Diabetes-Modified Behavioral Activation Treatment
NCT03593694
Impact of Brain Connectome and Personality on Cognitive Rehabilitation in Multiple Sclerosis
NCT03306875
EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking
NCT03262662
Recovery and Outcomes From Stroke
NCT04007757
Innovation Labs to Enhance Collaboration
NCT05395286
Perspective on Thoughts and Feelings as a Predictor of Psychological Well-being in Daily Life, in a Community Sample
NCT03336710
Validating an Inexpensive Practice Model for Microsurgical Skills Training
NCT04093063
The Effect of Botulinum Toxin A on Headache Attributed to TMD
NCT03346252
Maintaining Optimal Trauma Outcomes: Resilience in the Midst of a Ransomware Attack
NCT04881279
Aligning With Schools To Help Manage Asthma (Project ASTHMA)
NCT03032744
Impact of Periodontal Therapy on Patients With Diabetes
NCT04830969
Infant Environment Study
NCT02936284
Feasibility of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
NCT02954809
Defining and Treating Depression-related Asthma
NCT04617015
Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery
NCT02836990
Validation of a Computed Tomography (CT) Based Fractional Flow Reserve (FFR) Software Using the 320 Detector Aquilion ONE CT Scanner.
NCT03149042
Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia
NCT02892994
Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST)
NCT02722499
Computed Tomography for Evaluating Supination-external Rotation Type Ankle Fractures
NCT02599441
Repeat Emergency Department Visits Among Patients With Asthma and COPD
NCT02499887
Neonatal Microbiome Validity Study
NCT02655250
Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
NCT03046251
CT Analysis of the Patellofemoral Joint in Patients Having Knee Surgery
NCT02257099
Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial
NCT02295644
Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.
NCT02278588
An Exercise App to Reduce Young Adults' MJ Use
NCT01863095
Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum
NCT02163434
Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer
NCT02121652
Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis
NCT02651545
Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI
NCT02111447
Effects of Acthar on Recovery From Cognitive Relapses in MS
NCT02290444
Maintenance Gabapentin to Prolong Pregnancy.
NCT02056899
Nitrous Oxide Induction Induces Amnesia in Pediatric Patients
NCT02050152
Technology Intensified Diabetes Education Study in African Americans
NCT02088658
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 15 |
| Phase 3 | 7 |
| Phase 4 | 12 |
What is open in the State University of New York at Buffalo pipeline
52 recruiting of 243 indexed (21% open); 156 completed (64%).
Phase mix: 19 late (III/IV) vs 26 early (I/II) (balanced across stages).
Top condition: Multiple Sclerosis (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
State University of New York at Buffalo: open-pipeline peers nationwide
Peers matched on 243 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
State University of New York at Buffalo sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 243 trials (± recruiting share)
- Shire · 245 trials · 0% recruiting
- University of Cincinnati · 245 trials · 14% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
- Incyte Corporation · 239 trials · 15% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Axsome Therapeutics · 21% recruiting · 28 trials
- GOG Foundation · 21% recruiting · 14 trials
- Kettering Health Network · 21% recruiting · 14 trials
- LifeBridge Health · 21% recruiting · 14 trials
Related
What to do with this State University of New York at Buffalo page
243 registered trials is a research-attention snapshot, not an endorsement of State University of New York at Buffalo or any single study.
- 52 of State University of New York at Buffalo's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition State University of New York at Buffalo studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. State University of New York at Buffalo pipeline card: 243 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.